Cell motility plays an essential role in many physiological responses, such as development, immune reaction, and angiogenesis. In the present study, we showed that lysophosphatidic acid (LPA) modulates cancer cell migration by regulation of generation of reactive oxygen species (ROS). Stimulation of SKOV-3 ovarian cancer cells with LPA strongly promoted migration. but this migration was completely blocked by pharmacological inhibition of phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway. Inhibition of the ERK pathway had no effect on migration. Stimulation of SKOV-3 ovarian cancer cells with LPA significantly induced the generation of ROS in a time-dependent manner. LPA-induced generation of ROS was significantly blocked by pharmacological inhibition of PI3K or Akt, but inhibition of the ERK signaling pathway had little effect. LPA-induced generation of ROS was blocked by pretreatment of SKOV-3 ovarian cancer cells with an NADPH oxidase inhibitor, whereas inhibition of xanthine oxidase, cyclooxygenase, or mitochondrial respiratory chain complex I had no effect. Scavenging of ROS by N-acetylcysteine completely blocked LPA-induced migration of SKOV-3 ovarian cancer cells. Inhibition of NADPH oxidase blocked LPA-induced migration whereas inhibition of xanthine oxidase, cyclooxygenase, or mitochondrial respiratory chain complex I did not affect LPA-induced migration of SKOV-3 ovarian cancer cells. Given these results, we suggest that LPA induces ROS generation through the PI3K/Akt/NADPH oxidase signaling axis, thereby regulating cancer cell migration.
Introduction
Cell migration plays crucial roles in both physiology and pathophysiology such as embryonic development, immune system activation, angiognenesis, inflammation, wound healing, and cancer cell metastasis [18, 26, 28] . The speed and direction of cell migration are controlled by complex mechanisms involving morphological changes. For example, membrane rufflings such as laemellipodia and filopodia are formed by dynamic coordination of cytoskeletal rearrangement [18, 28] . Major responsible factors for morphological change and directional migration are known to be microtubules, integrins, and small G proteins such as Rac and CDC42 [6, 7, 35] . Directionality of cell migration is acquired by local activation of Rac or Ras where its local activation of phosphatidylinositol 3-kinase (PI3K) renders establishment of phosphoinositide gradient at the plasma membrane [30, 33] . Basically, PI3K catalyzes phosphatidylinositol 4,5-bis phosphate (PIP2) to generate more acidic phospholipid, phosphatidylinositol 3,4,5-trisphosphate (PIP3). Accumulation of PIP3 at membrane ruffling region enables cells to recruit a number of signaling molecules including Rac guanine nucleotide exchange factors (GEFs) and downstream effector molecules such as Wiskott-Aldrich syndrome protein (WASP) and WASP-family verprolin homologous protein (WAVE) [9, 23, 29] .
In normal serum or body fluids, a lipid ligand, lysophosphatidic acid (LPA, 1-or 2-acyl-sn-glycero-3-phosphate) normally exists. High level of LPA is detected not only in ascitic fluids but also in the plasma of ovarian cancer patients thereby regarded as a biomarker for ovarian cancer [37] . LPA modulates many cellular physiologies. In particular, it has been reported that LPA stimulates migration in various cell types including endothelial cells and fibroblasts [24, 25] . In addition, LPA modulates migration of cancer cells such as ovarian cancer cells and rat hepatoma cells [8, 14] . Recently, it also has been reported that LPA synergistically induces cancer cell migration in the presence of growth factors [15] .
The mechanism by which LPA regulates cancer cell migration is still unclear. It has been reported that LPA activates G protein-coupled receptors (GPCRs) such as LPA1/Edg-2, LPA2/Edg-4, and LPA3/Edg-7LPA thereby exerts its biological function [5] . Occupation of LPA receptors by LPA triggers signaling activation to induce migration in a variety of cells. For example, LPA activates the Ras/ MEKK/mitogen activated protein kinase (MAPK) pathway, p38 mitogen-activated protein kinase (p38 MAPK), and c-Jun N-terminal kinase (JNK) [2, 21] . In addition, PI3K is also activated by LPA stimulation. It has been reported that PI3K is activated by two different mechanisms. For example, LPA activates class I PI3K through transactivation of epidermal growth factor (EGF) receptor or directly activates class II PI3K [20, 32] . Although the involvement of PI3K in LPA-induced cancer cell migration in evident, the mechanism by which PIP3 regulates migration of cancer cell is still ambiguous. Recent evidence has supported that PIP3 can directly activate Rac small G protein to induced the formation of membrane ruffling. However, further downstream of PIP3/Rac signaling pathway is still unclear.
Reactive oxygen species (ROS) are generated by many different type extracellular stimuli [19] . Particularly, LPA significantly generates ROS in both macrophages and ovarian cancer cells thereby regulate mitogen-activated protein kinase (MAPK) signaling and proliferation [3, 31] . However, the involvement of ROS in LPA-induced cancer cell migration is still unclear. In this study, we suggest that LPA induces cancer cell migration through PI3K/NADPH oxidase pathways.
Materials and Methods

Materials
All culture media were purchased from Hyclone Laboratories Inc. (Logan, UT, USA). ChemoTx membrane (8 μm pore size) was obtained from Neuro Probe Inc. 
Statistical analysis
Results are expressed as the mean±S.D. of three independent experiments (n=3 for each experiment). When comparing two groups, an unpaired Student's t-test was used to assess differences. P-values less than 0.05 were con-sidered significant.
Results
LPA induces migration of SKOV-3 ovarian cancer cells
To ascertain capability of LPA in the induction of migration, we have examined chemotactic migration of SKOV-3 ovarian cancer cells by LPA. As shown in Fig. 1A , LPA significantly induced migration of SKOV-3 ovarian cancer cells. Since LPA activates variety of signaling molecules, we examined which one is important for the LPA-induced migration of SKOV-3 ovarian cancer cells. As shown in Fig. 1B , pharmacological inhibition of PI3K using LY294002 (10 μM) significantly blocked LPA-induced migration of SKOV-3 ovarian cancer cells. In addition, inhibition of Akt by SH-5 (10 μM) completely abrogated LPA-induced migration of SKOV-3 ovarian cancer cells. However, inhibition of ERK by PD98059 (10 μM) did not affect LPA-induced migration of SKOV-3 ovarian cancer cells. These results suggest that PI3K/Akt signaling pathway is important for LPA-induced migration of SKOV-3 ovarian cancer cells.
LPA induces ROS generation through the activation of PI3K signaling pathway
Since ROS is generated by various extracellular stimuli [19], we examined production of ROS after stimulation of SKOV-3 ovarian cancer cells with LPA. As shown in Figs 
LPA induces ROS generation through NADPH oxidase system
It has been reported that xanthine oxidase, eicosanoids, Our study demonstrated that PI3K regulated the generation of ROS in cancer cells (Fig. 2) . The mechanism by which PI3K regulates ROS generation is still not clear.
However, recent report suggested that platelet-derived growth factor (PDGF) induces translocation of Rac1 and p47 phox in PI3K-dependent mechanism [1] . Since Rac1 and p47 phox are components of NADPH oxidase system, translocation of these two components supposed to lead activation of NADPH oxidase at plasma membrane thereby induces generation of ROS. Likewise, it is possible that LPA also activates PI3K to induce the activation of Rac followed by activation of NADPH oxidase. It is still unclear how PIP3
which is a catalytic product of PI3K leads to the activation of Rac. One possible mechanism might be activation of P-Rex1 which is a guanine nucleotide exchange factor (GEF)
for Rac. P-Rex1 has pleckstrin homology (PH) domain, known as binding domain for PIP3, and two DEP domains, known as binding domain for Gβγ [12, 34, 36] . Therefore, it is possible that G protein-coupled LPA receptor evokes activation of PI3K and release of Gβγ subunit and leads to the activation of P-Rex1. In line with this, it has been reported that LPA induces cancer cell migration through the activation of P-Rex1 [15] .
In the present study, one important issue arises against Rac [11] . On the other hand, overexpression of dominant negative form of Akt suppresses Rac activation. It also has been reported that silencing of Akt1 significantly reduced growth factor-induced activation of Rac [16] . Currently, the mechanism by which Akt regulates Rac activation is still unknown. One possible mechanism seems to be molecular complex formation of Akt, P-Rex1, and Rac with mTOR. For instance, Akt1 and P-Rex1 co-immunoprecipitated with mTOR [10] , and confocal microscopic analysis revealed that Akt1, P-Rex1, and Rac co-localized at membrane ruffling region [16] . Therefore, Akt may relay the PI3K signals to Rac by formation of molecular complex and lead to the generation of ROS.
A number of evidence supports that growth factor receptor-induced ROS generation is key regulator for cell migration [13, 22] . However, little is known about the involvement of ROS in LPA-induced cancer cell migration. In the present study, two major findings are suggested. First, LPA generates ROS through the activation of NADPH oxidase (Fig. 3) . Second, generation of ROS is important for LPA-induced migration of SKOV-3 ovarian cancer cells (Fig. 4) . It is possible that the first issue involving mechanism of ROS generation seems to be regulated by P-Rex1/Rac signaling pathway as we mentioned above. However, it is still unclear how ROS regulates cell migration. One plausible mechanism seems to be enhancement of signaling capacity by modifying various molecules. For example, ROS can directly activate Src kinases by oxidizing its cysteine residues or indirectly by inhibiting protein tyrosine phosphatase (PTP) [4] . It also has been reported that inactivation of PTEN is achieved by ROS and this process is critical step for the activation of PI3K [27] . Therefore, it is possible that ROS can modulate signaling cascade involving regulatory mechanism of cancer cell migration. 
